About Uncharacterized protein CXorf58
Uncharacterized protein CXorf58 (CXorf58) is a protein
from Homo sapiens identified by UniProt accession
Q96LI9, 332 residues long.
MolForge cross-references it against 0 known binders and
15 disease associations.
Target properties
| Protein name | Uncharacterized protein CXorf58 |
| UniProt accession | Q96LI9 |
| Gene | CXorf58 |
| Organism | Homo sapiens |
| Length | 332 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (15)
Diseases linked to this target (Open Targets).
- concentration of large VLDL particles measurement · score 0.14
- total lipids in large VLDL · score 0.13
- phospholipids in medium VLDL measurement · score 0.13
- concentration of small VLDL particles · score 0.11
- total lipids in small VLDL · score 0.10
- phospholipids in large VLDL measurement · score 0.10
- cholesterol in large VLDL measurement · score 0.10
- cholesterol in very large VLDL measurement · score 0.10
- free cholesterol in large VLDL measurement · score 0.10
- triglycerides in VLDL measurement · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96LI9-F1 | alphafold | PREDICTED | 76.12 | — |
Amino-acid sequence (332 residues)
MNRSSNVPRK GILKSGTRSL QKVRRVHFAN ARNARSLLSM LKDISAQIIQ RAWLSHTNKM IFRLLKHAIC AAEFYVTHEI LKKVAPLEAK LIKDPTMQCK IRFRFRGETF PPFIVFKIFL HTDGHGYKYF SGKNVLMPSS KAVDDACKLM GERKFHRIIM EDERIFPKSK VTDIMDVVTM QDYVQYRSFF DEAPAFSGGR NNSWRKLNLE NIPRTMLMYD IVHYSESGVI SNRLRNEMKF LLQRPVTQEI HKHQLRIVSE IRGPYLTVQP LYRPYKQQNQ VKFLGRRSKQ AQMKVEKMRK VYLAKEKNTS EVTEPKTGPS GTKDNYHLHS IF
Explore Uncharacterized protein CXorf58 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets